Doosan Enerbility's most recent close was down 5.88% from the prior session. Korea's nuclear-themed ETFs have also been through a correction, down in the 25–30% range over the last 20 trading days.
At the same time, the company's order backlog stands at 24 trillion KRW, while the stock itself is down more than 40% from its 52-week high. Backlog and share price are moving in opposite directions — the point worth digging into.
The numbers
- Revenue, trailing four quarters: 17.6 trillion KRW (+10.6% year over year)
- Operating profit: 853.8 billion KRW (+6.5%)
- Free cash flow (operating cash flow minus capex): 330 billion KRW — under 1% of market cap
Growth is holding up, but free cash flow is thin — a function of the power-equipment and nuclear EPC business, which keeps requiring large, ongoing capital investment.
The real question is margin
What the market is watching more closely than the top line is margin. The Enerbility division's standalone operating margin is estimated to be sitting in the low single digits, around 3%. That means backlog is building faster than it's converting into profit.
Domestic market flows haven't helped either — capital has concentrated in semiconductors this year, leaving nuclear and industrial-equipment names broadly overlooked.
A telling comparison
The international comparison is stark. GE Vernova, in the same power-equipment business, is up 45% year to date. Doosan Enerbility is down 44%.
Even within nuclear-themed ETFs, the split is sharp: the large-cap nuclear ETFs are down 25–30% over the last 20 trading days, while ETFs specializing in small modular reactors (SMRs) are up 19.6% over the same stretch — the only ones in the green.
Where the market disagrees
Sell-side sentiment is still constructive: the median target price sits around 140,000 KRW, with most analysts maintaining buy ratings. Foreign ownership is at 23.9%, above its trailing average of 21.1%.
The question is whether the backlog actually turns into margin improvement. Until a real margin signal shows up, the gap between the share price and the fundamentals can keep persisting.
This is a data summary, not investment advice. Figures are sourced from public disclosures and exchange data at the time of writing and may have changed since. Do your own research before making any investment decision.
Originally tracked as part of K-Chain Radar's daily value-chain series — follow along on X (@KChainRadar).
Comments
Post a Comment